Gees - this is becoming difficult.
I will spell it out plain and simple - just like I have always stated - there will be no other ann before the AGM people - that's it.
The big one that all the speculation was/is about was the Arup deal...they would afterall be deemed to be "another party".
It's a good deal for ECT.
Why? Because right now (as I have previously posted) ECT are running low on cash...very low.
ECT does not have the funds to complete DFT!
They were going to use Monash funds for this, which as we all know, right now, have not eventuated.
Arup are taking shares, DFT will be completed and ECT do not have to fork out real tangible cash for the rest of DFT.
Arup creates a facility of up to $2.5 mill in fees, which should see DFT completed, but also allow for further Arup services and fees post DFT.
So, yes, there is further share dilution to accomodate Arup, but what other choice did ECT have in light of the Monash fiasco?
Go to the market for a CR?
Go to GW - remember they still owe $1.3 mill to GW for the tax rebate - has that been paid back to GW or does ECT still hold this rebate to use as working capital because they have no other cash source?
...and SDPR knows the above to be true - don't you?
Hence the diversion away from don't worry about this week people, it's all about December now - 3rd week maybe, pressies under the Xmas tree, etc, etc.
Beware those that speakth with forked tongue!
Forked = crytic in this context.
Well, I for one, hope you have all been good boys and girls this year so that Santa brings you all a nice big surprise for Xmas!
;o)
Cheers K
As always, happy to be proven wrong.
- Forums
- ASX - By Stock
- what can we expect this week
Gees - this is becoming difficult.I will spell it out plain and...
-
- There are more pages in this discussion • 111 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ECT (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $6.343M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
12 | 4230565 | 0.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.3¢ | 15229133 | 22 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
12 | 4230565 | 0.002 |
27 | 35956532 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.003 | 15229133 | 22 |
0.004 | 7303519 | 10 |
0.005 | 3296859 | 21 |
0.006 | 3178567 | 7 |
0.007 | 918333 | 2 |
Last trade - 16.12pm 12/11/2024 (20 minute delay) ? |
Featured News
ECT (ASX) Chart |
Day chart unavailable
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online